Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nadja Salomon
Observed names:
N Salomon,
Salomon, Nadja
Institutions:
University Medical Center of the Johannes Gutenberg University Mainz,
Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Observed institutions:
Johannes Gutenberg University Mainz,
University Medical Center of the Johannes Gutenberg University Mainz,
BioNTech (Germany),
Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
ORCID:
0000-0001-8097-593X
Observed ORCID:
0000-0001-8097-593X
OpenAlex ID:
A5035953108
mRNA therapeutics in cancer immunotherapy
2021
·
Jan D. Beck
, Daniel Reidenbach
, et al.
·
Molecular Cancer
·
425
PDF
The landscape of T cell antigens for cancer immunotherapy
2023
·
Aviyah Peri
, Nadja Salomon
, et al.
·
Nature Cancer
·
147
HPV16 RNA-LPX vaccine mediates complete regression of aggressively growing HPV-positive mouse tumors and establishes protective T cell memory
2019
·
Christian Grunwitz
, Nadja Salomon
, et al.
·
OncoImmunology
·
121
PDF
A liposomal RNA vaccine inducing neoantigen-specific CD4 + T cells augments the antitumor activity of local radiotherapy in mice
2020
·
Nadja Salomon
, Fulvia Vascotto
, et al.
·
OncoImmunology
·
53
PDF
Targeting the tumor vasculature with engineered cystine-knot miniproteins
2020
·
Bonny Gaby Lui
, Nadja Salomon
, et al.
·
Nature Communications
·
31
PDF
Local radiotherapy and E7 RNA-LPX vaccination show enhanced therapeutic efficacy in preclinical models of HPV16+ cancer
2021
·
Nadja Salomon
, Abderaouf Selmi
, et al.
·
Cancer Immunology Immunotherapy
·
27
PDF
A non-functional neoepitope specific CD8+ T-cell response induced by tumor derived antigen exposure in vivo
2018
·
Mathias Vormehr
, Katharina Reinhard
, et al.
·
OncoImmunology
·
18
PDF
Carbon Ion and Photon Radiation Therapy Show Enhanced Antitumoral Therapeutic Efficacy With Neoantigen RNA-LPX Vaccines in Preclinical Colon Carcinoma Models
2023
·
Nadja Salomon
, Alexander Helm
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
7
PDF
CIMT 2019: report on the 17th Annual Meeting of the Association for Cancer Immunotherapy
2019
·
Jan David Beck
, Matthias Birtel
, et al.
·
Human Vaccines & Immunotherapeutics
·
2
CIMT 2018: Pushing frontiers in cancer immunotherapy — Report on the 16th Annual Meeting of the Association for Cancer Immunotherapy
2018
·
Jan Beck
, Matthias Birtel
, et al.
·
Human Vaccines & Immunotherapeutics
·
1
Messenger RNA delivery of a dual CD25/CD122 affinity-tuned IL-2 variant prolongs exposure and potentiates antitumor T cell immunity
2026
·
Mathias Vormehr
, Lena M. Kranz
, et al.
·
Science Advances
PDF
Immune Responses to Radiation in Soft Tissue Sarcoma
2026
·
Claudia Fournier
, Peter Dick
, et al.
·
International Journal of Particle Therapy
mRNA-basierte Neoepitop-Tumorvakzinierung induziert effektive T-Zell-Antworten im HCC
2026
·
N Salomon
, P Schneider
, et al.
·
Zeitschrift für Gastroenterologie
OS-015 Personalized RNA-based tumor vaccines targeting neoantigens in hepatocellular carcinoma
2026
·
Paul Schneider
, Jenny Schunke
, et al.
·
Journal of Hepatology
Show more works
View as search
Works count:
15
Citation count:
832
H-index:
7
I10-index:
7
Year
Topic
Type